Carina Vingsbo Lundberg

Carina Vingsbo Lundberg


Carina Vingsbo Lundberg , Bakterier, parasitter og svampe / Kontraktforskning
T. +45 32688209 @.

Research area

Preclinical evaluation of antimicrobial drugs in in vivo infection models.


Head of contract research


  • Racine E, Nordmann P, Pantel L, Sarciaux M, Serri M, Houard J, Villain-Guillot P, Demords A, Vingsbo Lundberg C, Gualtieri M. 2018 In vitro and In vivo characterization of NOSO-502, a novel inhibitor of bacterial translation. Antimicrob Agents Chemother. Aug 27;62(9). pii: e01016-18. doi: 10.1128/AAC.01016-18. (In press)
  • Pantel L, Florin T, Dobosz-Bartoszek M, Racine E, Sarciaux M, Serri M, Houard J, Campagne JM, de Figueiredo RM, Midrier C, Gaudriault S, Givaudan A, Lanois A, Forst S, Aumelas A, Cotteaux-Lautard C, Bolla JM, Vingsbo Lundberg C, Huseby DL, Hughes D, Villain-Guillot P, Mankin AS, Polikanov YS, Gualtieri M.i: 2018. Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal Site. Mol Cell. 70(1):83-94
  • M Vaara, T Vaara, C  Vingsbo Lundberg. 2018. Polymyxin derivatives NAB739 and NAB815 are more effective than polymyxin B in murine Escherichia coli pyelonephritis. J Antimicrob Chemother. 73(2):452-455
  • TT Hoang, CS  Aagaard, J Dietrich, J Cassidy, G Dolganov, G Schoolnik, C Vingsbo Lundberg, E Agger, P Andersen. 2013 Differential effect of ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure Tuberculosis vaccination. PlosOne 8(12)
  • C Vingsbo Lundberg, N Frimodt-Møller. 2013. Efficacy of topical and systemic antibiotic treatment of methicillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model. International Journal of Antimicrobial Agents 42:272-275